The post-Theranos world.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 35136231.
- Also identified by DOI 10.1038/s41587-022-01242-0 and PMC identifier 9106795.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Advances in technology and changes to healthcare during the pandemic may finally realize the vision of patient-centric blood testing espoused by disgraced Theranos CEO Elizabeth Holmes.
Medical subject headings
- Diagnostic Techniques and Procedures